| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |